ASCENTAGE PHARMA GR-ADR (AAPG) Stock Price, Quote, News and Overview
NASDAQ:AAPG - Nasdaq - ADR - Currency: USD
AAPG Quote, Performance and Key Statistics
NASDAQ:AAPG (3/7/2025, 8:03:01 PM)
19.93
+0.49 (+2.52%)
The current stock price of AAPG is 19.93 USD. In the past month the price increased by 6.01%.
AAPG Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.17 | 378.30B | ||
| AMGN | AMGEN INC | 16.39 | 174.51B | ||
| GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
| ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
| BIIB | BIOGEN INC | 9.13 | 22.01B | ||
| NTRA | NATERA INC | N/A | 19.02B | ||
| GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
Related stock screener links
About AAPG
Company Profile
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company, which engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 574 full-time employees. The company went IPO on 2019-10-28. The firm focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The firm's main products include the next-generation kinase inhibitor: HQP1351 and apoptosis targeted drugs APG-1252, APG2575, APG-115 and so on. The firm conducts businesses within the domestic market and to overseas markets, including the United States.
Company Info
ASCENTAGE PHARMA GR-ADR
68 Xinqing Road, Suzhou Industrial Park
Suzhou JIANGSU CN
Employees: 574
Company Website: https://www.ascentage.cn/
Investor Relations: http://www.ascentage.com/investor-relations/stock-information/
ASCENTAGE PHARMA GR-ADR / AAPG FAQ
What is the stock price of ASCENTAGE PHARMA GR-ADR today?
The current stock price of AAPG is 19.93 USD. The price increased by 2.52% in the last trading session.
What is the ticker symbol for ASCENTAGE PHARMA GR-ADR stock?
The exchange symbol of ASCENTAGE PHARMA GR-ADR is AAPG and it is listed on the Nasdaq exchange.
On which exchange is AAPG stock listed?
AAPG stock is listed on the Nasdaq exchange.
What is ASCENTAGE PHARMA GR-ADR worth?
ASCENTAGE PHARMA GR-ADR (AAPG) has a market capitalization of 1.74B USD. This makes AAPG a Small Cap stock.
How many employees does ASCENTAGE PHARMA GR-ADR have?
ASCENTAGE PHARMA GR-ADR (AAPG) currently has 574 employees.
What are the support and resistance levels for ASCENTAGE PHARMA GR-ADR (AAPG) stock?
ASCENTAGE PHARMA GR-ADR (AAPG) has a support level at 19.2 and a resistance level at 21.17. Check the full technical report for a detailed analysis of AAPG support and resistance levels.
Is ASCENTAGE PHARMA GR-ADR (AAPG) expected to grow?
The Revenue of ASCENTAGE PHARMA GR-ADR (AAPG) is expected to grow by 120.73% in the next year. Check the estimates tab for more information on the AAPG EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ASCENTAGE PHARMA GR-ADR (AAPG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AAPG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AAPG, evaluating the profitability, health, valuation and growth aspects
- ASCENTAGE PHARMA GR-ADR (AAPG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ASCENTAGE PHARMA GR-ADR (AAPG) Sales and EPS estimates to see what analysts future expectations are.
- ASCENTAGE PHARMA GR-ADR (AAPG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ASCENTAGE PHARMA GR-ADR (AAPG) Insider and Institutional Ownership to learn about the owners and their transactions.
- ASCENTAGE PHARMA GR-ADR (AAPG) Stock Chart to make your own analysis
- ASCENTAGE PHARMA GR-ADR (AAPG) Latest news and press-releases to stay up to date.
Does ASCENTAGE PHARMA GR-ADR (AAPG) stock pay dividends?
AAPG does not pay a dividend.
When does ASCENTAGE PHARMA GR-ADR (AAPG) report earnings?
ASCENTAGE PHARMA GR-ADR (AAPG) will report earnings on 2025-03-26, after the market close.
What is the Price/Earnings (PE) ratio of ASCENTAGE PHARMA GR-ADR (AAPG)?
ASCENTAGE PHARMA GR-ADR (AAPG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.58).
AAPG Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to AAPG.
AAPG Financial Highlights
Over the last trailing twelve months AAPG reported a non-GAAP Earnings per Share(EPS) of -0.58. The EPS increased by 61.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.6% | ||
| ROE | -47.01% | ||
| Debt/Equity | 1.42 |
AAPG Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 88% to AAPG. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 61.78% and a revenue growth 120.73% for AAPG